Clovis Oncology to Announce Fourth Quarter/Year End 2013 Financial Results and
Host Webcast Conference Call on February 27
BOULDER, Colo., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Clovis Oncology, Inc.
(Nasdaq:CLVS) will announce its fourth quarter/year end 2013 financial results
on Thursday, February 27, 2014, after the close of the U.S. financial markets.
Clovis' senior management will host a conference call and live audio webcast
on Thursday, February 27, at 4:30 p.m. ET to discuss the company's results in
The conference call is being webcast and can be accessed from the Clovis
Oncology website at www.clovisoncology.com.A replay of the webcast will be
available for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring,
developing and commercializing innovative anti-cancer agents in the U.S.,
Europe and additional international markets. Clovis Oncology targets
development programs at specific subsets of cancer populations, and
simultaneously develops diagnostic tools that direct a compound in development
to the population that is most likely to benefit from its use. Clovis Oncology
is headquartered in Boulder, Colorado.
CONTACT: Anna Sussman
Press spacebar to pause and continue. Press esc to stop.